166 related articles for article (PubMed ID: 12644474)
1. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter.
Cheema SK; Mishra SK; Rangnekar VM; Tari AM; Kumar R; Lopez-Berestein G
J Biol Chem; 2003 May; 278(22):19995-20005. PubMed ID: 12644474
[TBL] [Abstract][Full Text] [Related]
2. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
3. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
5. Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3.
Chendil D; Das A; Dey S; Mohiuddin M; Ahmed MM
Cancer Biol Ther; 2002; 1(2):152-60. PubMed ID: 12170775
[TBL] [Abstract][Full Text] [Related]
6. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.
Johnstone RW; See RH; Sells SF; Wang J; Muthukkumar S; Englert C; Haber DA; Licht JD; Sugrue SP; Roberts T; Rangnekar VM; Shi Y
Mol Cell Biol; 1996 Dec; 16(12):6945-56. PubMed ID: 8943350
[TBL] [Abstract][Full Text] [Related]
7. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
[TBL] [Abstract][Full Text] [Related]
8. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4.
Qiu G; Ahmed M; Sells SF; Mohiuddin M; Weinstein MH; Rangnekar VM
Oncogene; 1999 Jan; 18(3):623-31. PubMed ID: 9989812
[TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
Brett A; Pandey S; Fraizer G
Mol Cancer; 2013 Jan; 12():3. PubMed ID: 23298185
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers.
Keating GL; Reid HM; Eivers SB; Mulvaney EP; Kinsella BT
Biochim Biophys Acta; 2014 Jun; 1839(6):476-92. PubMed ID: 24747176
[TBL] [Abstract][Full Text] [Related]
11. Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1).
Wagner KD; Wagner N; Wellmann S; Schley G; Bondke A; Theres H; Scholz H
FASEB J; 2003 Jul; 17(10):1364-6. PubMed ID: 12738801
[TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
Vetterkind S; Boosen M; Scheidtmann KH; Preuss U
Int J Oncol; 2005 Jan; 26(1):159-67. PubMed ID: 15586236
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
[TBL] [Abstract][Full Text] [Related]
14. Wilms' tumor suppressor gene (WT1) suppresses apoptosis by transcriptionally downregulating BAX expression in immature rat granulosa cells.
Park M; Choi Y; Choi H; Roh J
J Ovarian Res; 2014 Dec; 7():118. PubMed ID: 25491731
[TBL] [Abstract][Full Text] [Related]
15. In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation.
Boehrer S; Chow KU; Beske F; Kukoc-Zivojnov N; Puccetti E; Ruthardt M; Baum C; Rangnekar VM; Hoelzer D; Mitrou PS; Weidmann E
Cancer Res; 2002 Mar; 62(6):1768-75. PubMed ID: 11912153
[TBL] [Abstract][Full Text] [Related]
16. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
Bourkoula K; Englert C; Giaisi M; Köhler R; Krammer PH; Li-Weber M
Int J Cancer; 2014 Jan; 134(2):291-300. PubMed ID: 23832418
[TBL] [Abstract][Full Text] [Related]
17. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
18. [Downregulation of PAR expression induces the apoptosis of human prostate cancer PC3 cells and increases the Bcl-2/Bax ratio].
Xu XF; Zhou XM; Wei ZF; Zhang ZY; Ge JP; Wei W; Zhou WQ; Cheng W; Hou JQ; Gao JP
Zhonghua Nan Ke Xue; 2012 Oct; 18(10):896-9. PubMed ID: 23297497
[TBL] [Abstract][Full Text] [Related]
19. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells.
Huang H; Zegarra-Moro OL; Benson D; Tindall DJ
Oncogene; 2004 Mar; 23(12):2161-76. PubMed ID: 14676836
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.
Eisermann K; Tandon S; Bazarov A; Brett A; Fraizer G; Piontkivska H
BMC Genomics; 2008 Jul; 9():337. PubMed ID: 18631392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
